Cargando…
Evaluation of the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy in atypical histologic subtypes of primary and metastatic mediastinal malignancies
BACKGROUND: We aimed to evaluate the efficacy and feasibility of concurrent weekly docetaxel-nedaplatin and hypo-fractionated radiotherapy (hypo-RT) in atypical histologic subtypes of primary and metastatic mediastinal malignancies. METHODS: Fifty-four patients diagnosed with atypical primary or met...
Autores principales: | Meng, FanJun, Ai, XinLei, Wang, Bin, Zhou, Yin, Li, Su, Wang, DaQuan, Liu, FangJie, Chen, NaiBin, Zhou, Rui, Guo, JinYu, Huang, XiaoYan, Yin, ShaoHan, Qiu, Bo, Liu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585306/ https://www.ncbi.nlm.nih.gov/pubmed/36276120 http://dx.doi.org/10.3389/fonc.2022.974394 |
Ejemplares similares
-
Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022) -
Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045)
por: Zhou, Rui, et al.
Publicado: (2023) -
A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer
por: Huo, LanQing, et al.
Publicado: (2023) -
Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma
por: Peng, Pei-Jian, et al.
Publicado: (2015) -
Concurrent chemoradiotherapy with raltitrexed and nedaplatin regimen for esophageal squamous cell carcinoma
por: Qiu, Xiangnan, et al.
Publicado: (2020)